Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs

European Surgical Research

Volumn 29, Issue 2, 1997, Pages 133-141

  Abu Zidan, Fikri M ^a   Walther, S ^a   Lennquist, S ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antagonist; Aortic clamping; Platelet activating factor; Postischemic shock; Reperfusion

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; CARDIOVASCULAR DISEASE; CELIAC ARTERY; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART OUTPUT; HYPERGLYCEMIA; HYPOTENSION; ISCHEMIA; LACTIC ACIDEMIA; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SHOCK; SWINE;

EID: 0031047203     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129517     Document Type: Article

References (38)

1. Abu-Zidan FM, Walther S, Lenn-quist S: Modulation of lung injury by platclct-activating factor antagonism in non-hypotensive porcine cndotoxcmia. Circ Shock 1994:44: 148-153.
2. Abu-Zidan FM. Walther S: Platelet-activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs. EurJ Surg 1996:162:499-504.
3. Abu-Zidan FM. Walther S. Lenn-quist S: Role of platelet-activating factor antagonism in post-hemor-rhage septic shock in pigs. J Trauma 1996:41:634-640.
4. Abu-Zidan FM. Walther S. Lcnn-quist S: Role of platelet-activating factor antagonism in haemorrhagic shock in pigs. Fur Surg Res 1995:27: 379-388.
5. Abu-Zidan FM. Walther S. Lenn-quist S: BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs. Pharmacol Toxicol 1996:78: 23-27.
6. Filep J, Herman F, Braquel P, Mozcs T: Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Commun 1989;158:353-359.
7. Sagach VF. Dmitrieva AV. Braquct P: Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF). Lipids 1991:26: 1400-1403.
8. Fukuoka T, Nakajima Y, Nakano H: The platelet activating factor as a pivotal mediator of shock after liver ischemia. Surg Today 1995:25:351-356.
9. Wilson DV. Stick JA: Effect of specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischaemia in anesthetised ponies. Am J Vet Res 1993:54:443-448.
10. Mathieson MA, Dunham BM, Hu-val WV, Lelcuk S, Stcmp LI, Valeri C'R: Ischemia of the limb stimulates thromboxane production and myocardial dcpresssion. Surg Gynecol Obstct 1983;157:500-504.
11. Gadalcta D. Fantini GA. Silanc MF. Davis JM: Neutrophil leukotricne generation and pulmonary dysfunction after abdominal aortic aneurysm repair. Surgery 1994:116:847-852.
12. Lefcr AM: Significance of lipid mediators in shock states. Circ Shock 1989:27:3-12.
13. Anncr H, Kaufman RP, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Pulmonary hypertension and leukoscqueslration after lower torso ischemia. Ann Surg 1987:206:642-648.
14. Huval WV, Lelcuk S, Allen PD, Mannick JA, Shepro D, Hechtman HB: Determinants of cardiovascular stability during abdominal aortic aneurysmectomy (AAA). Ann Surg 1984:199:216-222.
15. Rabinovici R, Yuc T, Fcucrs:cin G: Platclct-activating factor in cardiovascular stress situations. Lipids 1991:26:1257-1263.
16. Snedecor GW, Cochran WG: Statistical Methods, ed 7. Ames, Iowa State University Press, 1980: pp 215-237.
17. Perry MO: The hemodynamics of temporary abdominal aortic occlusion. Ann Surg 1968:168:193-200.
18. Mansberger AR Jr. Cox EF. Flotte CT. Buxton RW: Washout acidosis following resection of aortic aneurysms: clinical metabolic study of reactive hyperemia and effect of Dextran on excess lactate and pH. Ann Surg 1966. 163:778-787.
19. Brant B. Armstrong RP. Vctlo RM: Vasodepressor factor in declamp shock production. Surgery 1970:67: 650-653.
20. Fry WJ. Keitzer WF. Kraft RO. De Wccsc MS: Prevention of hypotension due to aortic release. Surg Gynecol Obstct 1963:116:301-306.
21. Andersson J, Eklof B, Neglen P, Thomson D: Metabolic changes in blood and skeletal muscle in reconstructive aortic surgery. Ann Surg 1979:189:283-289.
22. Cunningham AJ, O'Toole DP, McDonald N, Keeling F, Bouchicr-Hayes D: The influence of collateral vascularisation on haemodynamic performance during abdominal aortic surgery. Can J Anesthesiol 1989: 36:44-50.
23. Abu-Ncma T, Avvash K, Bemtman L, Matani Y, Sigurdsson GH, Francis I, Hellckant C: Intraaortic balloon tamponade during hemorrhagic shock in sheep. Circ Shock 1988: 24:55-62.
24. Lalak N. Englund R. Morris R. Gibb D. Jaques T: The effect of infrarcnal aortic cross clamping and dcclamp-ingon renal function in the pig. Aust NZJ Surg 1995:65:201-204.
25. Gamulin Z, Forster A, Morel D, Si-monet F, Aymon E, Favre H: Effects of infrarenal aortic cross-clamping on hemodynamics in humans. Anesthesiology 1984. 61:394-399.
26. Laurindo FRM. Goldstein RE. Davenport NJ. Ezra D. Feuerstein GZ: Mechanism of hypotension produced by platelet-activating factor. J Appl Physiol 1989;66:2681-2690.
27. Graham RM. Strahan ME. Norman KW. Watkins DN. Sturm MJ. Taylor RR: Platelet and platclct-activating factor in sepsis and myocardial infarction. J Lipid Mediat Cell Signal 1994:9:167-182.
28. Mozes T, Zijlstra FJ, Hciligers JPC, Tak CJAM, Bcn-Efraint S, Bonta I, Saxena PR: Sequential release of tumour necrosis factor, platelet activating factor, and eicosanoids during endotoxin shock in anaesthetized pigs: Protective effects of indo-mcthacin. Br J Pharmacol 1991: 104:691-699.
29. Hcuer HO, Darius H, Lohmann HF, Meyer J, Schicrcnbcrg M, Trecsc N: Platelet activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 1991:26:1381-1385.
30. Hw ang S: Specific receptors of platelet-activating factor, receptor heterogeneity and signal transduction mechanisms. J Lipid Mediat 1990; 2:123-158.
31. Christodoulou MS, Rothaul AL, Whittaker M, Wood LM: Effect of lexipafant, a selective PAF receptor antagonist on ischaemia induced cardiac arrhythmia and mortality in the anaesthetised rabbit (abstract). Br J Pharmacol 1995;116(suppl): 40P.
32. Wakefield TW. Lindblad B. Stanley TJ. et al: Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery. Eur J Vase Surg 1994:8:193-198.
33. Bowald S. Gcrdin B: Pulmonary mi-croembolism during and after aortic cross-clamping in heparinized and non-heparinized pigs. Acta Chir Scand 1980:146:351-356.
34. Bowald S, Eriksson I, Wiklund L: Effects of aortic occlusion in heparinized and non-heparinized pigs. Acta Chir Scand 1980:146:343-349.
35. Bowald S, Eriksson I, Wiklund L: The influence of heparin on haemo-dynamics and blood gases during abdominal aortic surgery'. Acta Chir Scand 1980;146:333-341.
36. Sasaki M. Herd CM. Page CP: Effect of heparin and low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits. Br J Pharmacol 1993:110:107-112.
37. Lambrecht G. Parnham MJ: Kad-surenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes. Br J Pharmacol 1986:87:287-289.
38. Evans TW, Chung KF, Rogers DF, Barnes PJ: Effect of platelet-activating factor on airway vascular permeability: Possible mechanisms. J Appl Physiol 1987:63:479-484.